144 related articles for article (PubMed ID: 33511942)
1. Current Perspectives on the Role of Nrf2 in 5-Fluorouracil Resistance in Colorectal Cancer.
Gong J; Xu H
Anticancer Agents Med Chem; 2021; 21(17):2297-2303. PubMed ID: 33511942
[TBL] [Abstract][Full Text] [Related]
2. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer.
Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980
[TBL] [Abstract][Full Text] [Related]
3. The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.
Zhou S; Ye W; Duan X; Zhang M; Wang J
Dig Dis Sci; 2013 Jun; 58(6):1615-26. PubMed ID: 23314856
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
[TBL] [Abstract][Full Text] [Related]
5. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
[TBL] [Abstract][Full Text] [Related]
6. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.
Kang KA; Piao MJ; Kim KC; Kang HK; Chang WY; Park IC; Keum YS; Surh YJ; Hyun JW
Cell Death Dis; 2014 Apr; 5(4):e1183. PubMed ID: 24743738
[TBL] [Abstract][Full Text] [Related]
8. S-Adenosylmethionine Increases the Sensitivity of Human Colorectal Cancer Cells to 5-Fluorouracil by Inhibiting P-Glycoprotein Expression and NF-κB Activation.
Mosca L; Pagano M; Borzacchiello L; Mele L; Russo A; Russo G; Cacciapuoti G; Porcelli M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502219
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
10. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
11. iASPP-Mediated ROS Inhibition Drives 5-Fu Resistance Dependent on Nrf2 Antioxidative Signaling Pathway in Gastric Adenocarcinoma.
Wen L; Yang S; Li P; Chen R; Wang Q; Kaspo B; Fan H; Hu J
Dig Dis Sci; 2020 Oct; 65(10):2873-2883. PubMed ID: 31938994
[TBL] [Abstract][Full Text] [Related]
12. A Bioactive Compound from
Zhang W; Peng C; Shen X; Yuan Y; Zhang W; Yang C; Yao M
Molecules; 2021 Jun; 26(13):. PubMed ID: 34202548
[TBL] [Abstract][Full Text] [Related]
13. The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer.
Heydari K; Saidijam M; Sharifi MR; Dermani FK; Soleimani Asl S; Shabab N; Najafi R
Pathol Oncol Res; 2018 Jan; 24(1):145-151. PubMed ID: 28411308
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.
Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J
Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
17. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.
Yang Y; Ma L; Xu Y; Liu Y; Li W; Cai J; Zhang Y
Cell Death Dis; 2020 Jun; 11(6):477. PubMed ID: 32581212
[TBL] [Abstract][Full Text] [Related]
18. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells.
Sakatani A; Sonohara F; Goel A
Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
